BridgeMD
New treatment option for Preterm Infant Development
Official title Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development
ClinicalTrials.gov ID: NCT07306000
What this study is testing
- What it's testing
- Close Collaboration with Parents intervention is an evidence-based educational intervention for the entire multi-professional staff of neonatal intensive care units (NICUs). The goal of the intervention is to strengthen partnership between staff and parents, enhance parental participation in infant care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 7
You may be able to join if
- preterm infants born below 32 weeks of gestation and/or weighing \< 1500 g who receive long-term follow-up at each study site.
You likely can't join if
- the infant has any major anomalies
- the infants are triplets or higher order
- the infant's condition is critical and the survival is uncertain
- the parents cannot understand the informed consent form in Korean or in Japanese
The study team makes the final eligibility decision.
Where it's taking place
- Matsumoto, Nagano, Japan
- Kyoto, Japan
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 hour to 7 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Matsumoto, Nagano, Japan; Kyoto, Japan; Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.